Seth Lederman

Seth Lederman

Chief Executive OfficeratTonix Pharmaceuticals Holding· In proxies 2023–2025

Pay in FY2025+75% from the year before · Tonix Pharmaceuticals Holding stock -52.6% the same year

Seth Lederman was paid $3.2M in FY2025 (Dec), up 75%. Tonix Pharmaceuticals Holding stock fell 52.6% that year.

Pay$100 in the stock at the end of FY22 → $0
Pay is from the Summary Compensation Table of each Tonix Pharmaceuticals Holding proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Tonix Pharmaceuticals HoldingPublic company · 3 yr
    • Chief Executive Officer2023 – Present · 3 yrStock in role -100%
  2. Konanda Pharma Fund I, LPPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?